Bank of America
DAWN

Bank of America’s Day One Biopharmaceuticals DAWN Stock Holding History

Bank of America’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.8M Buy
1,902,868
+819,050
+76% +$11.5M ﹤0.01% 1748
2025
Q4 		$10.1M Sell
1,083,818
-108,033
-9% -$903K ﹤0.01% 2843
2025
Q3 		$8.4M Buy
1,191,851
+226,428
+23% +$1.56M ﹤0.01% 3469
2025
Q2 		$6.28M Sell
965,423
-81,333
-8% -$559K ﹤0.01% 3666
2025
Q1 		$8.3M Buy
1,046,756
+1,026,222
+4,998% +$11.1M ﹤0.01% 3327
2024
Q4 		$260K Sell
20,534
-171,660
-89% -$2.39M ﹤0.01% 5975
2024
Q3 		$2.68M Buy
192,194
+14,528
+8% +$207K ﹤0.01% 4315
2024
Q2 		$2.45M Buy
177,666
+50,077
+39% +$733K ﹤0.01% 4285
2024
Q1 		$2.11M Sell
127,589
-32,295
-20% -$483K ﹤0.01% 4409
2023
Q4 		$2.33M Sell
159,884
-58,717
-27% -$712K ﹤0.01% 4250
2023
Q3 		$2.68M Buy
218,601
+5,129
+2% +$66.9K ﹤0.01% 3990
2023
Q2 		$2.55M Sell
213,472
-20,118
-9% -$263K ﹤0.01% 3999
2023
Q1 		$3.12M Buy
233,590
+109,117
+88% +$2.13M ﹤0.01% 3983
2022
Q4 		$2.68M Sell
124,473
-31,732
-20% -$651K ﹤0.01% 3993
2022
Q3 		$3.13M Buy
156,205
+126,498
+426% +$2.69M ﹤0.01% 3861
2022
Q2 		$532K Buy
29,707
+23,857
+408% +$246K ﹤0.01% 5400
2022
Q1 		$58K Buy
5,850
+165
+3% +$2.18K ﹤0.01% 7114
2021
Q4 		$96K Buy
5,685
+5,201
+1,075% +$107K ﹤0.01% 6900
2021
Q3 		$11K Sell
484
-216
-31% -$5.18K ﹤0.01% 7543
2021
Q2 		$16K Buy
+700
New +$14.6K ﹤0.01% 7193

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Bank of America's DAWN Position: Q1 2026 in Review

Bank of America increased its Day One Biopharmaceuticals (DAWN) stake by 76% in Q1 2026, buying an estimated $11.5M and bringing the position to 1,902,868 shares worth $40.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

Bank of America first reported a position in DAWN in Q2 2021 and has held it in 20 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Bank of America held 1,902,868 shares of Day One Biopharmaceuticals worth $40.8M as of Q1 2026.
  • Bank of America bought 819,050 Day One Biopharmaceuticals shares in Q1 2026, an estimated $11.5M.
  • Day One Biopharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1748 holding.
  • Bank of America first reported a position in Day One Biopharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.